Therapeutic potential of xtr-miR-22-3p from Plastrum testudinis in acute promyelocytic leukemia

IF 1.3 3区医学 Q3 CHEMISTRY, APPLIED

Journal of Asian Natural Products Research Pub Date : 2024-09-11 DOI:10.1080/10286020.2024.2395566

Ming-Yang Chen, Meng Li, Qing-Yi Xu, Shu-Wang Zhang, Guang-Xi Ren, Chun-Sheng Liu

引用次数: 0

Abstract

Acute promyelocytic leukemia (APL) is marked by a block at the promyelocyte stage. Treatments like ATRA and ATO face resistance and relapse issues. Plastrum testudinis, a traditional Chinese medici...

查看原文本刊更多论文

Plastrum testudinis 中的 xtr-miR-22-3p 对急性早幼粒细胞白血病的治疗潜力

急性早幼粒细胞白血病（APL）的特征是早幼粒细胞阶段的阻滞。ATRA和ATO等治疗方法面临耐药性和复发问题。传统中药 "板蓝根 "可用于治疗急性早幼粒细胞白血病（APL）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Asian Natural Products Research 医学-药学

CiteScore

3.20

自引率

5.90%

发文量

审稿时长

2.3 months

期刊介绍： The Journal of Asian Natural Products Research (JANPR) publishes chemical and pharmaceutical studies in the English language in the field of natural product research on Asian ethnic medicine. The journal publishes work from scientists in Asian countries, e.g. China, Japan, Korea and India, including contributions from other countries concerning natural products of Asia. The journal is chemistry-orientated. Major fields covered are: isolation and structural elucidation of natural constituents (including those for non-medical uses), synthesis and transformation (including biosynthesis and biotransformation) of natural products, pharmacognosy, and allied topics. Biological evaluation of crude extracts are acceptable only as supporting data for pure isolates with well-characterized structures. All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by at least two expert referees.